A.B.O.S.: Application examples of the IT-based analysis for biological data

(PresseBox) - The new analysis technique A.B.O.S. allows a quick recording, classification and evaluation of biological properties or processes in complex databases.
For the first time, application examples were introduced in public?at the Annual meeting of the Swiss Society for Microbiology 2015. At the poster presentation, the analysis of E. coli strains and discrimination of dermatophytes were explained, see attachment.

Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: PresseBox
Datum: 19.06.2015 - 13:49 Uhr
Sprache: Deutsch
News-ID 401760
Anzahl Zeichen: 453

contact information:
Town:

Esslingen

Kategorie:

Handcrafts

Diese Pressemitteilung wurde bisher 317 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"A.B.O.S.: Application examples of the IT-based analysis for biological data"
steht unter der journalistisch-redaktionellen Verantwortung von

BioTeSys GmbH (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

The art of designing clinical trials with dietary supplements ...

In order to be assessed by the European Food and Safety Authority (EFSA), claims on effects and efficacy of selected ingredients regarding health require verification and sub-stantiation by clinical trials in vivo. This applies to any kind of biolog ...

BioTeSys joins BioEconomy Network for the Production of Bio-based Products ...

BioTeSys deploys its competencies in the area of bio-based economy. As part of the Central Innovation Programme for SME (ZIM) projects are driven that take into account the change from a petroleum-based to a sustainable economy, based on renewable r ...

BioTeSys takes off with new website ...

The Nutritional CRO and Test laboratory goes online with a completely restructured website. The three business fields of BioTeSys introduced themselves in a user-friendly design, outlined the product groups of their investigations, and detailed thei ...

Alle Meldungen von BioTeSys GmbH